Phase 4 Breast cancer trials recruiting now

All Breast cancer trials, every phase

Other phases for Breast cancer

Phase 4 Breast cancer trials

• A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients
  NCT07578064 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• A Study for the Adjuvant Treatment of Breast Cancer
  NCT05420467 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• A Study for the Neoadjuvant Treatment of Breast Cancer
  NCT05420454 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
  NCT07220967 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 7 locations
• A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
  NCT06274515 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations
• A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
  NCT06934239 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
  NCT04136782 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Female · 7 locations
• An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
  NCT05376878 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
  NCT07357597 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 78 locations
• Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
  NCT06072807 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 1 location
• CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
  NCT05206331 · Phase: Phase 4 · Ages: 30 Years and older · Sex: Female · 1 location
• Cardiotoxicity in Breast Cancer Patients
  NCT06491680 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
  NCT05525767 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
  NCT05362760 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 54 locations
• Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
  NCT05452213 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 52 locations
• DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
  NCT07158164 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
  NCT04790305 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 34 locations
• Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
  NCT04373564 · Phase: Phase 4 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 102 locations
• Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
  NCT07252726 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer
  NCT04921137 · Phase: Phase 4 · Ages: 70 Years and older · Sex: All (male and female) · 8 locations
• Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
  NCT05753618 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
  NCT07308717 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 7 locations
• Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis
  NCT06230055 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies
  NCT06252662 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
  NCT03096418 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 2 locations
• OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk
  NCT05333328 · Phase: Phase 4 · Ages: 20 Years to 50 Years · Sex: Female · 2 locations
• Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
  NCT07695259 · Phase: Phase 4 · Ages: 60 Years and older · Sex: Female · 1 location
• Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
  NCT06429761 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
  NCT06574022 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
  NCT07600164 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
  NCT05465031 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 8 locations
• Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.
  NCT07195344 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
  NCT06641544 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
  NCT06217185 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
  NCT07257484 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 2 locations
• Viscum Album for TNBC on Adjuvant Pembrolizumab
  NCT06920810 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.